Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India.

Joseph P, Desai VB, Mohan NS, Fredrick JS, Ramachandran R, Raman B, Wares F, Ramachandran R, Thomas A.

Indian J Med Res. 2011 May;133:529-34.

2.

Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis?

Vadwai V, Boehme C, Nabeta P, Shetty A, Alland D, Rodrigues C.

J Clin Microbiol. 2011 Jul;49(7):2540-5. doi: 10.1128/JCM.02319-10. Epub 2011 May 18.

3.

Culture conversion among HIV co-infected multidrug-resistant tuberculosis patients in Tugela Ferry, South Africa.

Brust JC, Lygizos M, Chaiyachati K, Scott M, van der Merwe TL, Moll AP, Li X, Loveday M, Bamber SA, Lalloo UG, Friedland GH, Shah NS, Gandhi NR.

PLoS One. 2011 Jan 6;6(1):e15841. doi: 10.1371/journal.pone.0015841.

4.

Rapid molecular detection of tuberculosis and rifampin resistance.

Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O'Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodrigues C, Alland D, Perkins MD.

N Engl J Med. 2010 Sep 9;363(11):1005-15. doi: 10.1056/NEJMoa0907847. Epub 2010 Sep 1.

5.

Tuberculosis management by private practitioners in Mumbai, India: has anything changed in two decades?

Udwadia ZF, Pinto LM, Uplekar MW.

PLoS One. 2010 Aug 9;5(8):e12023. doi: 10.1371/journal.pone.0012023.

6.

High survival and treatment success sustained after two and three years of first-line ART for children in Cambodia.

Isaakidis P, Raguenaud ME, Te V, Tray CS, Akao K, Kumar V, Ngin S, Nerrienet E, Zachariah R.

J Int AIDS Soc. 2010 Mar 21;13:11. doi: 10.1186/1758-2652-13-11.

7.

Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa.

Heller T, Lessells RJ, Wallrauch CG, Bärnighausen T, Cooke GS, Mhlongo L, Master I, Newell ML.

Int J Tuberc Lung Dis. 2010 Apr;14(4):420-6.

PMID:
20202299
8.

Timing of initiation of antiretroviral drugs during tuberculosis therapy.

Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A, Gengiah T, Nair G, Bamber S, Singh A, Khan M, Pienaar J, El-Sadr W, Friedland G, Abdool Karim Q.

N Engl J Med. 2010 Feb 25;362(8):697-706. doi: 10.1056/NEJMoa0905848.

9.

HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality.

Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott M, Weissman D, Marra C, Lalloo UG, Friedland GH; Tugela Ferry Care and Research (TF CARES) Collaboration..

Am J Respir Crit Care Med. 2010 Jan 1;181(1):80-6. doi: 10.1164/rccm.200907-0989OC. Epub 2009 Oct 15.

PMID:
19833824
10.

Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern Africa.

Seung KJ, Omatayo DB, Keshavjee S, Furin JJ, Farmer PE, Satti H.

PLoS One. 2009 Sep 25;4(9):e7186. doi: 10.1371/journal.pone.0007186.

11.

Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis.

Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM.

PLoS One. 2009 Sep 9;4(9):e6914. doi: 10.1371/journal.pone.0006914. Review.

12.

Seven-year DOTS-Plus pilot experience in India: results, constraints and issues.

Singla R, Sarin R, Khalid UK, Mathuria K, Singla N, Jaiswal A, Puri MM, Visalakshi P, Behera D.

Int J Tuberc Lung Dis. 2009 Aug;13(8):976-81.

PMID:
19723377
13.

Excellent outcomes among HIV+ children on ART, but unacceptably high pre-ART mortality and losses to follow-up: a cohort study from Cambodia.

Raguenaud ME, Isaakidis P, Zachariah R, Te V, Soeung S, Akao K, Kumar V.

BMC Pediatr. 2009 Aug 20;9:54. doi: 10.1186/1471-2431-9-54.

14.

High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India.

D'souza DT, Mistry NF, Vira TS, Dholakia Y, Hoffner S, Pasvol G, Nicol M, Wilkinson RJ.

BMC Public Health. 2009 Jun 29;9:211. doi: 10.1186/1471-2458-9-211.

15.

Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis.

Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, Gandhi NR, Galvani AP.

Lancet Infect Dis. 2009 Mar;9(3):153-61. doi: 10.1016/S1473-3099(09)70041-6. Review.

PMID:
19246019
16.

Increasing incidence of fluoroquinolone-resistant Mycobacterium tuberculosis in Mumbai, India.

Agrawal D, Udwadia ZF, Rodriguez C, Mehta A.

Int J Tuberc Lung Dis. 2009 Jan;13(1):79-83.

PMID:
19105883
17.

Multidrug-resistant tuberculosis treatment outcomes in Karakalpakstan, Uzbekistan: treatment complexity and XDR-TB among treatment failures.

Cox HS, Kalon S, Allamuratova S, Sizaire V, Tigay ZN, Rüsch-Gerdes S, Karimovich HA, Kebede Y, Mills C.

PLoS One. 2007 Nov 7;2(11):e1126.

18.

Feasibility and cost-effectiveness of treating multidrug-resistant tuberculosis: a cohort study in the Philippines.

Tupasi TE, Gupta R, Quelapio MI, Orillaza RB, Mira NR, Mangubat NV, Belen V, Arnisto N, Macalintal L, Arabit M, Lagahid JY, Espinal M, Floyd K.

PLoS Med. 2006 Sep;3(9):e352.

19.

Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia.

Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S, Barnashov A, Karpeichik Y, Andreev YG, Golubchikova VT, Tonkel TP, Yanova GV, Nikiforov M, Yedilbayev A, Mukherjee JS, Furin JJ, Barry DJ, Farmer PE, Rich ML, Keshavjee S.

Int J Tuberc Lung Dis. 2006 Apr;10(4):402-8. Erratum in: Int J Tuberc Lung Dis. 2006 Oct;10(10):1183. Mishustin, S [added]; Barnashov, A [added]; Karpeichik, Y [added].

PMID:
16602404
20.

Tuberculosis epidemiology in India: a review.

Chadha VK.

Int J Tuberc Lung Dis. 2005 Oct;9(10):1072-82. Review.

PMID:
16229217

Supplemental Content

Support Center